Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine.
A safe and effective vaccine against RSV remains an important unmet public health need. Intranasally (IN) delivered live-attenuated vaccines represent the most extensively studied approach for immunization of RSV-naïve infants and children, however, achieving an effective balance of attenuation and...
Main Authors: | Rachel Groppo, Joshua DiNapoli, Kwang Il Jeong, Michael Kishko, Nicholas Jackson, Harold Kleanthous, Simon Delagrave, Linong Zhang, Mark Parrington |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6007926?pdf=render |
Similar Items
-
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner.
by: Kwang-Il Jeong, et al.
Published: (2015-01-01) -
Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
by: Jennifer N. Rainho-Tomko, et al.
Published: (2022-06-01) -
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein.
by: Judith Alamares-Sapuay, et al.
Published: (2024-01-01) -
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein
by: Judith Alamares-Sapuay, et al.
Published: (2024-01-01) -
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)